Morningstar - AECOM (ACM) AECOMs fundamental growth trajectory, driven from projects in emerging markets, remains intact.

Report

Morningstar

David Silver

EUR 101.80 For Business Accounts Only

AECOM's fundamental growth trajectory, driven from projects in emerging markets, remains intact.

AECOM Technology has grown into one of the largest global providers of engineering and construction (E&C) and management services, with a primary focus on infrastructure work and project services for government clientele. It operates a fully integrated service model with in-house capabilities to design, build, finance, and operate a broad range of projects including skyscrapers, major sports and entertainment venues, high-speed rail, and the operation and management of defense systems and eq...

09/06/2017 13 EN

Underlying

AECOM

AECOM designs, builds, finances and operates infrastructure assets for governments, businesses and organizations. The company provides: planning, consulting, architectural and engineering design services to commercial and government clients in transportation, facilities, environmental, energy, water and government markets; construction services, including building construction and energy, infrastructure and industrial construction; as well as program and facilities management and maintenance, training, logistics, consulting, technical assistance, and systems integration and information technology services, for agencies of the United States government and for other national governments.

See profile

US00766T1007 New York Stock Exchange United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

David Silver

Other Reports on these Companies

Moody's Investors Service

Moody's assigns Baa3 rating to AECOM's amended credit facilities

Moody's Ratings (Moody's) assigned a Baa3 rating to AECOM's amended and extended credit facilities, including a new $1.5 billion senior secured revolving credit facility, a $750 million senior secured term loan A, and a $700 million senior secured term loan B. The ratings on the existing credit faci...

EUR 168.93

April 5, 2024 April 5, 2024 1 EN

Vermilion Research

Vermilion Compass: Weekly Equity Strategy

Downgrading Real Estate to Underweight Our bullish outlook we initiated on November 7, 2023 remains intact; this intermediate-to-long-term outlook is likely to stay in place as long as 4800 support holds on the S&P 500 (implying 7-10% downside) and market dynamics remain healthy. To be clear, we are not calling for a pullback to 4800; we view it as a worst-case scenario for the S&P 500, and we simply want to be prepared for anything. Shorter-term, we remain bullish on the S&P 500 and Nasdaq 100 (QQQ) as they both refuse to close below their 20-day MAs for more than 2-3 consecutive days. If we...

EUR 46.93

March 26, 2024 March 26, 2024 1 EN

Vermilion Research

Vermilion Compass: Weekly Equity Strategy

Yesterday's hotter-than-expected CPI report continues to suggest a more restrictive Fed policy than the market has been expecting. This raises the possibility of further consolidation for small- and mid-caps. Meanwhile, large-cap indexes (S&P 500, Nasdaq 100) remain bullish, finding support at their respective 20-day MAs since November 2023; the only question is whether that will continue to be the case, as our main concern remains rising Treasury yields and the U.S. dollar (DXY), which have broken above short-term resistance levels as of yesterday. Friday's PPI report should provide more clar...

EUR 46.93

February 14, 2024 February 14, 2024 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

AECOM's fundamental growth trajectory, driven from projects in emerging markets, remains intact.

Moody's assigns Baa3 rating to AECOM's amended credit facilities

Vermilion Compass: Weekly Equity Strategy

Vermilion Compass: Weekly Equity Strategy

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe